Godavari Biorefineries received a patent from China for its new anti-cancer molecule. The China National Intellectual Property Administration granted the patent. Sathgen Therapeutics, Godavari's biotech division, developed the molecule. The molecule, HYDROXY-1,4-NAPHTHALENEDIONE, shows promise in fighting cancer. In vitro studies showed it inhibits cancer and cancer stem cells. It is effective against breast and prostate cancer cells.